PROVIDER PROFILE · NPI 1093980617
Afshin Mohammadi
PRESCRIBING · PART D · 2024
Total Rx claims
1,279
Beneficiaries
—
Total drug cost
$234K
Distinct drugs
33
Brand share
48.8%
Top prescribed drugs
Fremanezumab-Vfrm223 claims
Carbidopa/Levodopa206 claims
Levetiracetam112 claims
Gabapentin92 claims
Sumatriptan Succinate65 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
CROSS-REFERENCE